Center for Substance Abuse Treatment; Notice of Meeting, 28500 [2017-13054]

Download as PDF 28500 Federal Register / Vol. 82, No. 119 / Thursday, June 22, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: HIV/AIDS Innovative Research Applications. Date: July 6, 2017. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mark P Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1775, rubertm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities. Date: July 14, 2017. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Biao Tian, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089B, MSC 7848, Bethesda, MD 20892, (301) 402–4411, tianbi@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Language and Communication. Date: July 17, 2017. Time: 8:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Biao Tian, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089B, MSC 7848, Bethesda, MD 20892, (301) 402–4411, tianbi@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cell and Molecular Biology. Date: July 18–19, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Amy Kathleen Wernimont, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 16:08 Jun 21, 2017 Jkt 241001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6198, Bethesda, MD 20892, 301–827–6427, amy.wernimont@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK. Date: July 18, 2017. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Raul Rojas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6185, Bethesda, MD 20892, (301)451–6319, rojasr@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 16, 2017. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2017–12979 Filed 6–21–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council (NAC) will meet on August 10, 2017, 8:30 a.m.–5:00 p.m. (EDT). The meeting is open and will include consideration of minutes from the SAMHSA CSAT NAC meeting of February 1, 2017, the Director’s Report, a budget update, discussions of the 90/ 90/90 targets, discussion of quality improvement, SAMHSA Leadership Discussion with CSAT Council Members, an update on the 21st Century Cures Act implementation. The meeting will be held at the SAMHSA 5600 Fishers Lane, Conference Room 5W37, Rockville, MD 20857. Attendance by the public will be limited to space available and will be limited to the open sessions of the meeting. Interested persons may present data, information, or views, orally or in writing, on issues pending before the PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Council. Written submissions should be forwarded to the contact person on or before August 1, 2017. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact person on or before August 1, 2017. Five minutes will be allotted for each presentation. The open meeting session may be accessed via telephone. To attend on site, obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https://nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with the CSAT National Advisory Council Designated Federal Officer; Tracy Goss (see contact information below). Meeting information and a roster of Council members may be obtained by accessing the SAMHSA Committee Web site at https://www.samhsa.gov/about-us/ advisory-councils/csat-nationaladvisory-council or by contacting the CSAT National Advisory Council Designated Federal Officer; Tracy Goss (see contact information below). Council Name: SAMHSA’s Center for Substance Abuse Treatment, National Advisory Council Date/Time/Type: August 10, 2017, 8:30 a.m.—5:00 p.m. EDT, OPEN. Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Tracy Goss, Designated Federal Officer, CSAT National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), Telephone: (240) 276–0759, Fax: (240) 276–2252, Email: tracy.goss@ samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2017–13054 Filed 6–21–17; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Center for Substance Abuse Treatment (CSAT) National Advisory Council will meet on July 24, 2017, 2:00 p.m.–3:00 E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 82, Number 119 (Thursday, June 22, 2017)]
[Notices]
[Page 28500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Treatment; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Treatment (CSAT) National Advisory Council 
(NAC) will meet on August 10, 2017, 8:30 a.m.-5:00 p.m. (EDT).
    The meeting is open and will include consideration of minutes from 
the SAMHSA CSAT NAC meeting of February 1, 2017, the Director's Report, 
a budget update, discussions of the 90/90/90 targets, discussion of 
quality improvement, SAMHSA Leadership Discussion with CSAT Council 
Members, an update on the 21st Century Cures Act implementation.
    The meeting will be held at the SAMHSA 5600 Fishers Lane, 
Conference Room 5W37, Rockville, MD 20857. Attendance by the public 
will be limited to space available and will be limited to the open 
sessions of the meeting. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the Council. Written submissions should be forwarded to the contact 
person on or before August 1, 2017. Oral presentations from the public 
will be scheduled at the conclusion of the meeting. Individuals 
interested in making oral presentations are encouraged to notify the 
contact person on or before August 1, 2017. Five minutes will be 
allotted for each presentation.
    The open meeting session may be accessed via telephone. To attend 
on site, obtain the call-in number and access code, submit written or 
brief oral comments, or request special accommodations for persons with 
disabilities, please register on-line at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx, or communicate with the CSAT 
National Advisory Council Designated Federal Officer; Tracy Goss (see 
contact information below).
    Meeting information and a roster of Council members may be obtained 
by accessing the SAMHSA Committee Web site at https://www.samhsa.gov/about-us/advisory-councils/csat-national-advisory-council or by 
contacting the CSAT National Advisory Council Designated Federal 
Officer; Tracy Goss (see contact information below).
    Council Name: SAMHSA's Center for Substance Abuse Treatment, 
National Advisory Council
    Date/Time/Type: August 10, 2017, 8:30 a.m.--5:00 p.m. EDT, OPEN.
    Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857.
    Contact: Tracy Goss, Designated Federal Officer, CSAT National 
Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), 
Telephone: (240) 276-0759, Fax: (240) 276-2252, Email: 
tracy.goss@samhsa.hhs.gov.

Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017-13054 Filed 6-21-17; 8:45 am]
 BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.